NPP's approach toward improving rigor and transparency in clinical trials research

Sofiya Hupalo¹, Chloe J Jordan², Terri Bowen³, Jennifer Mahar⁴, Elizabeth Yepez⁵, Lori Kunath⁶, Sarah Timm⁶, Keri Martinowich^{7

8}, William A Carlezon Jr², Lisa M Monteggia⁹, Tony P George^{10

11}

Affiliations

¹ Division of Neuroscience and Basic Behavioral Science, National Institute of Mental Health, Bethesda, MD, 20892, USA.
² Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA, 02478, USA.
³ Origin Editorial, Cincinnati, OH, 45039, USA.
⁴ Origin Editorial and Editorial Evolution, Pembroke, MA, 02359, USA.
⁵ Springer Nature, New York, NY, 10004, USA.
⁶ American College of Neuropsychopharmacology, Brentwood, TN, 37027, USA.
⁷ Lieber Institute for Brain Development, Baltimore, MD, 21205, USA.
⁸ Department of Psychiatry and Behavioral Sciences; Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
⁹ Department of Pharmacology and the Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, 37240, USA.
¹⁰ Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Tony.George@camh.ca.
¹¹ Addictions Division and Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, ON, M6J1H4, Canada. Tony.George@camh.ca.

PMID: 36038779
PMCID: PMC9852433
DOI: 10.1038/s41386-022-01409-y

Editorial

NPP's approach toward improving rigor and transparency in clinical trials research

Sofiya Hupalo et al. Neuropsychopharmacology. 2023 Feb.

. 2023 Feb;48(3):429-431.

doi: 10.1038/s41386-022-01409-y. Epub 2022 Aug 29.

Authors

Affiliations

¹ Division of Neuroscience and Basic Behavioral Science, National Institute of Mental Health, Bethesda, MD, 20892, USA.
² Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, MA, 02478, USA.
³ Origin Editorial, Cincinnati, OH, 45039, USA.
⁴ Origin Editorial and Editorial Evolution, Pembroke, MA, 02359, USA.
⁵ Springer Nature, New York, NY, 10004, USA.
⁶ American College of Neuropsychopharmacology, Brentwood, TN, 37027, USA.
⁷ Lieber Institute for Brain Development, Baltimore, MD, 21205, USA.
⁸ Department of Psychiatry and Behavioral Sciences; Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
⁹ Department of Pharmacology and the Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, 37240, USA.
¹⁰ Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Tony.George@camh.ca.
¹¹ Addictions Division and Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, ON, M6J1H4, Canada. Tony.George@camh.ca.

PMID: 36038779
PMCID: PMC9852433
DOI: 10.1038/s41386-022-01409-y

No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors have roles at NPP. SH is the Editorial Intern; CJJ is the Special Projects Manager; TB and LK are Editorial Assistants; JM is the Managing Editor; ST is the Executive Director of ACNP; KM is the Social Media Editor; WAC is the outgoing Principal Editor; TPG and LMM are the incoming Principal Editors.

Figures

**Fig. 1. CONSORT flow diagram depicting the progression of participants through a clinical trial.**
Reproduced from [3].

See this image and copyright information in PMC

References

1. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10:28–55. doi: 10.1016/j.ijsu.2011.10.001. - DOI - PubMed
1. Han C, Kwak K, Marks DM, Pae C-U, Wu L-T, Bhatia KS, et al. The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. Contemp Clin Trials. 2009;30:116–22. doi: 10.1016/j.cct.2008.11.004. - DOI - PMC - PubMed
1. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18. doi: 10.1186/1741-7015-8-18. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

NPP's approach toward improving rigor and transparency in clinical trials research

Affiliations

NPP's approach toward improving rigor and transparency in clinical trials research

Authors

Affiliations

Conflict of interest statement

Figures

References

Publication types

LinkOut - more resources

Full Text Sources